Optimization of Antisense Oligonucleotide Drugs for Skipping Dystrophin Exon 51 and 53 in Duchenne Muscular Dystrophy

被引:0
|
作者
Wu, Bo [1 ]
机构
[1] Carolinas Med Ctr, Charlotte, NC 28203 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
315
引用
收藏
页码:148 / 148
页数:1
相关论文
共 50 条
  • [21] Eteplirsen treatment for Duchenne muscular dystrophy Exon skipping and dystrophin production
    Charleston, Jay S.
    Schnell, Frederick J.
    Dworzak, Johannes
    Donoghue, Cas
    Lewis, Sarah
    Chen, Lei
    Young, G. David
    Milici, Anthony J.
    Voss, Jon
    DeAlwis, Uditha
    Wentworth, Bruce
    Rodino-Klapac, Louise R.
    Sahenk, Zarife
    Frank, Diane
    Mendell, Jerry R.
    NEUROLOGY, 2018, 90 (24) : E2146 - E2154
  • [22] Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    Heemskerk, H. A.
    de Winter, C. L.
    van Putten, M.
    De Kimpe, S.
    van Deutekom, J. C. T.
    van Ommen, G. J. B.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 757 - 757
  • [23] NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
    Watanabe, Naoki
    Nagata, Tetsuya
    Satou, Youhei
    Masuda, Satoru
    Saito, Takashi
    Kitagawa, Hidetoshi
    Komaki, Hirofumi
    Takagaki, Kazuchika
    Takeda, Shin'ichi
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 13 : 442 - 449
  • [24] WVE-210201, an investigational stereopure oligonucleotide therapy for Duchenne muscular dystrophy, induces Exon 51 skipping and dystrophin protein restoration
    Wood, M.
    Zhang, J.
    Bowman, K.
    Butler, D.
    Rinaldi, C.
    McClorey, G.
    Frank-Kamenetsky, M.
    Iwamoto, N.
    Kothari, N.
    Lu, G.
    Mathieu, S.
    Meena, M.
    Menon, S.
    Shimizu, M.
    Standley, S.
    Yang, H.
    Zhong, A.
    Francis, C.
    Vargeese, C.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S217 - S217
  • [25] Golodirsen Induces Exon Skipping Leading to Sarcolemmal Dystrophin Expression in Duchenne Muscular Dystrophy Patients With Mutations Amenable to Exon 53 Skipping
    Muntoni, Francesco
    Frank, Diane
    Sardone, Valentina
    Morgan, Jenny
    Schnell, Fred
    Charleston, Jay
    Desjardins, Cody
    Phadke, Rahul
    Sewry, Caroline
    Popplewell, Linda
    Guglieri, Michela
    Bushby, Kate
    Carlier, Pierre
    Clark, Chris
    Dickson, George
    Hogrel, Jean-Yves
    Straub, Volker
    Mercuri, Eugenio
    Voit, Thomas
    Kaye, Edward
    Servais, Laurent
    NEUROLOGY, 2018, 90
  • [26] Development of Multiexon Skipping Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy
    Aoki, Yoshitsugu
    Yokota, Toshifumi
    Wood, Matthew J. A.
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [27] Antisense Oligonucleotide-Induced Multiexon Skipping in Duchenne Muscular Dystrophy
    Popplewell, L. J.
    Dickson, G.
    HUMAN GENE THERAPY, 2010, 21 (04) : 507 - 508
  • [28] Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    Janson, Anneke A. M.
    van Ommen, Gert-Jan B.
    van Deutekom, Judith C. T.
    BMC MEDICAL GENETICS, 2007, 8
  • [29] Antisense oligonucleotides mediated exon skipping therapy for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    van Ommen, G. J. B.
    van Deutekom, J. C. T.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1358 - 1358
  • [30] A multicenter comparison of quantification methods for antisense oligonucleotide- induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
    Hiller, Monika
    Falzarano, Maria Sofia
    Garcia-Jimenez, Iker
    Sardone, Valentina
    Verheul, Ruurd C.
    Popplewell, Linda
    Anthony, Karen
    Ruiz-Del-Yerro, Estibaliz
    Osman, Hana
    Goeman, Jelle J.
    Mamchaoui, Kamel
    Dickson, George
    Ferlini, Alessandra
    Muntoni, Francesco
    Aartsma-Rus, Annemieke
    Arechavala-Gomeza, Virginia
    Datson, Nicole A.
    Spitali, Pietro
    PLOS ONE, 2018, 13 (10):